Routine Screening for Central and Primary Adrenal Insufficiency during Immune-Checkpoint Inhibitor Therapy: An Endocrinology Perspective for Oncologists

Background: Immune checkpoint inhibitor (ICI)-associated hypothalamic–pituitary–adrenal axis disruption can lead to hypocortisolism. This is a life-threatening but difficult to diagnose condition, due to its non-specific symptoms that overlap with symptoms of malignancy. Currently, there is no conse...

Descripción completa

Detalles Bibliográficos
Autores principales: Druce, Irena, Tawagi, Karine, Shaw, Julie L. V., Ibrahim, Andrea, Lochnan, Heather, Ong, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315594/
https://www.ncbi.nlm.nih.gov/pubmed/35877230
http://dx.doi.org/10.3390/curroncol29070370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315594/
https://www.ncbi.nlm.nih.gov/pubmed/35877230
http://dx.doi.org/10.3390/curroncol29070370

Ejemplares similares